CRL - Charles River Laboratories International, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 56.34B
Enterprise Value 38.36B
Trailing P/E 29.26
Forward P/E 117.64
PEG Ratio (5 yr expected) 11.69
Price/Sales (ttm)2.59
Price/Book (mrq)4.35
Enterprise Value/Revenue 33.41
Enterprise Value/EBITDA 615.45

Trading Information

Stock Price History

Beta (3Y Monthly) 1.17
52-Week Change 36.68%
S&P500 52-Week Change 3-0.33%
52 Week High 3149.07
52 Week Low 3103.00
50-Day Moving Average 3135.74
200-Day Moving Average 3136.42

Share Statistics

Avg Vol (3 month) 3330.71k
Avg Vol (10 day) 3301.16k
Shares Outstanding 548.75M
Float 48.03M
% Held by Insiders 11.67%
% Held by Institutions 195.66%
Shares Short (Jul 31, 2019) 41.1M
Short Ratio (Jul 31, 2019) 43.73
Short % of Float (Jul 31, 2019) 42.57%
Short % of Shares Outstanding (Jul 31, 2019) 42.25%
Shares Short (prior month Jun 28, 2019) 41.29M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 29, 2018
Most Recent Quarter (mrq)Jun 29, 2019


Profit Margin 8.94%
Operating Margin (ttm)14.76%

Management Effectiveness

Return on Assets (ttm)5.32%
Return on Equity (ttm)16.50%

Income Statement

Revenue (ttm)2.45B
Revenue Per Share (ttm)50.75
Quarterly Revenue Growth (yoy)12.30%
Gross Profit (ttm)842.69M
EBITDA 541.16M
Net Income Avi to Common (ttm)218.89M
Diluted EPS (ttm)4.44
Quarterly Earnings Growth (yoy)-18.60%

Balance Sheet

Total Cash (mrq)201.48M
Total Cash Per Share (mrq)4.13
Total Debt (mrq)2.2B
Total Debt/Equity (mrq)148.90
Current Ratio (mrq)1.59
Book Value Per Share (mrq)29.82

Cash Flow Statement

Operating Cash Flow (ttm)401.62M
Levered Free Cash Flow (ttm)268.36M